Biogen Idec is expanding its Market Access team with special focus on Public Affairs, Patient Advocacy and Eastern Europe. We are looking forward to receiving your application at firstname.lastname@example.org
Biogen Idec creates new standards of care in therapeutic areas with high unmet medical needs. Founded in 1978, Biogen Idec is a global leader in the biotechnology industry in the discovery, development, manufacturing, and commercialization of innovative therapies. Patients in more than 90 countries benefit from Biogen Idec's significant products that address diseases such as lymphoma, multiple sclerosis, and rheumatoid arthritis.
Post a Comment